Intermittent hypoxic pretreatment exacerbates house dust mite-induced asthma airway inflammation

BackgroundAsthma is widely recognized as an inflammatory disorder. In the context of this inflammatory microenvironment, the involvement of hypoxia and its impact on related pathways have drawn considerable attention. However, the exact role of hypoxia, a prevalent environmental factor, in the development and progression of asthma remains poorly understood. MethodsMice were treated with house dust mite (HDM) extracts for 23 days to induce asthma. Mice were divided into room air (RA) group and intermittent hypoxic (IH) group by exposing to different conditions and IH preconditioning (IHP) were underwent to the above groups before the hypoxic regimen. Airway inflammation in mice was evaluated by airway hyperresponsiveness, excessive mucus secretion, and recruitment of inflammatory cells. Immunohistochemistry was employed to quantify the expression levels of NF-kappa B. Subsequently, the dose of allergen was modified to investigate whether the impact of hypoxia on asthma is affected by different doses of allergens. ResultCompared to the RA and IH groups, HDM-treated mice in the IHP group exhibited aggravated inflammatory cell infiltration and airway hyperresponsiveness (p <.05). Moreover, there was an increased release of inflammatory mediators and higher expression levels of NF-kappa B (p <.05). Importantly, the impact ia on asthma was found to be influenced by high dose of allergen (p <.05). ConclusionIHP treatment potentially exacerbates HDM-induced airway inflammation in asthma, with the involvement of NF-kappa B, particularly under high-dose allergen stimulation.